Mologic Achieves Breakthrough in Point-of-Care Diagnostics and Develops New Platform Technology
The novel diagnostics device delivers up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts of global epidemics
The novel diagnostics device delivers up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts of global epidemics
Don’t miss April’s highlights thanks to our regular monthly round-up of all the most popular stories and resources in the clinical science community
This new solution could enable large-scale AAV vector production for gene therapy
New hematologic biomarker has the potential to revolutionize clinicians’ approach to sepsis triage and diagnosis
Next-generation assay aids in diagnosing heart attacks faster and more accurately, and is enabled on the company’s newest analyzer, the VITROS® XT 7600 Integrated System
Rapid, label-free imaging and volumetric analysis via HT-2 microscope studies the 4D interaction dynamics of T cells and their targets in the immunological synapse for the first time
New system promises to deliver antibiotic susceptibility testing results in two hours to help avoid misuse of antibiotics in suspected sepsis patients
New isotype-specific secondary antibodies promise improved signal detection and specificity in imaging
Scientists based at the Moscow Institute of Physics and Technology have designed a portable device for rapid correction of hemostasis abnormalities – SelectScience editors find out more
The Unyvero Platform allows rapid testing for a broad range of pathogens and antibiotic resistance markers associated with life-threatening infections in hospitalized patients
Dr. Heather Brown discusses how to iron out variability in dried blood spot analysis with FIA-MS/MS
Catch up on all the biggest stories and top downloadable content in the clinical community in our monthly round-up
UK researchers hope rapid Actiphage® test could improve TB screening
The tripartite mRNA technology has completed its phase 1b study for direct, intranodal injections in adjuvant melanoma patients